Search
01/08/2022
Autoimmunity in the Study of Interstitial Lung Disease: Are Serological Test Enough?
Castellví I., Vidal S., Valenzuela C.. Autoimmunity in the Study of Interstitial Lung Disease: Are Serological Test Enough?. ARCHIVOS DE BRONCONEUMOLOGIA. 2022; 58(8)DOI:10.1016/j.arbres.2021.08.016. PMID:35312568. IF:8.000(Q1/2D).
01/08/2022
Management of progressive pulmonary fibrosis associated with connective tissue disease
Molina-Molina, M, Castellvi, I, Valenzuela, C, Ramirez, J, Portal, JAR, Franquet, T, Narvaez, J. Management of progressive pulmonary fibrosis associated with connective tissue disease. Expert Review of Respiratory Medicine. 2022; 16(7)DOI:10.1080/17476348.2022.2107508. PMID:35912842. IF:3.900(Q2/5D).
01/07/2022
Cutaneous adverse events with febuxostat after previous reactions to allopurinol: comment on the article by Singh and Cleveland
Quilis, N, Vela, P, Caceres, BAB, Diaz-Torne, C, Calvo-Aranda, E, Sivera, F, Prada-Ojeda, A, Ruiz, FP, Pascual, E, Andres, M. Cutaneous adverse events with febuxostat after previous reactions to allopurinol: comment on the article by Singh and Cleveland. ANNALS OF THE RHEUMATIC DISEASES. 2022; 81(7)DOI:10.1136/annrheumdis-2020-218226. PMID:32616605. IF:27.400(Q1/1D).
15/06/2022
Clinical Patterns and Follow-Up of Inflammatory Arthritis and Other Immune-Related Adverse Events Induced by Checkpoint Inhibitors. A Multicenter Study
Gomez-Puerta, JA, Lobo-Prat, D, Perez-Garcia, C, Ponce, A, Frade-sosa, B, Arciniegas, AMM, Ojeda, F, Ruiz-Esquide, V, Corominas, H. Clinical Patterns and Follow-Up of Inflammatory Arthritis and Other Immune-Related Adverse Events Induced by Checkpoint Inhibitors. A Multicenter Study. Frontiers in Medicine. 2022; 9DOI:10.3389/fmed.2022.888377. PMID:35783644. IF:3.900(Q2/4D).